prostate cancer Clinical Trials and Research
Also known as: prostate ca, pca, prostatic adenocarcinoma, localized prostate cancer, advanced prostate cancer, metastatic prostate cancer, castration-resistant prostate cancer · ICD-10: C61
Prostate cancer occurs when cells in the prostate gland grow out of control. Clinical trial research focuses on developing new treatments, improving early detection methods, and managing treatment side effects. Find a Trial helps patients search for active studies.
Search prostate cancer trials →
Common questions about prostate cancer clinical trials
What are the general eligibility requirements for prostate cancer clinical trials?
Eligibility criteria vary by study but often include age, cancer stage, and overall health. Patients must meet specific requirements to ensure their safety and the study's scientific integrity, as detailed on ClinicalTrials.gov.
What are the different phases of prostate cancer clinical trials?
Clinical trials for prostate cancer typically progress through phases 1, 2, and 3. Each phase evaluates different aspects, such as safety, dosage, and effectiveness, before a new treatment can be considered for wider use, according to data from ClinicalTrials.gov.
What are some active research directions in prostate cancer clinical trials?
Current research explores novel targeted therapies, immunotherapies, and advanced radiation techniques. Studies also investigate improved diagnostic tools and ways to reduce treatment side effects, as reported by NIH RePORTER and ClinicalTrials.gov.
What types of interventions are commonly studied in prostate cancer trials?
Common interventions include new chemotherapy drugs, hormone therapies, radiation therapy, and surgical techniques. Researchers also study precision medicine approaches based on genetic markers and supportive care interventions, according to ClinicalTrials.gov.
Are there specific biomarkers important in prostate cancer clinical trials?
Yes, Prostate-Specific Antigen (PSA) is a key biomarker for screening and monitoring. Other important biomarkers include genetic mutations like BRCA1/2 and ATM, which help identify patients for targeted therapies, as seen in studies on ClinicalTrials.gov.
Do patients have to pay to participate in prostate cancer clinical trials?
Generally, study-related medical costs, such as experimental treatments and tests, are covered by the trial sponsor. However, routine medical care costs may still be billed to insurance or the patient. Details are provided by the study team.
What are common reasons someone might be excluded from a prostate cancer trial?
Common exclusion criteria include other serious medical conditions, prior treatments that might interfere with the study drug, or specific cancer stages not relevant to the trial's focus. These criteria ensure patient safety and study validity, per ClinicalTrials.gov.
Do clinical trials focus on specific types or stages of prostate cancer?
Many trials target specific stages, such as early-stage, advanced, or metastatic prostate cancer. Some also focus on particular subtypes, like castration-resistant prostate cancer, to test highly specific treatments, as detailed on ClinicalTrials.gov.
How to find a prostate cancer trial that fits you
- Describe your prostate cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all prostate cancer trials →